BackDeciphera Pharmaceuticals Overview

Deciphera Pharmaceuticals Current Assets

Track Deciphera Pharmaceuticals's current assets ($350M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$349.94M
↓ 26.51% YoYΔ $-126.22M vs prior year quarter

Peer trimmed avg / median

Loading

Deciphera Pharmaceuticals Current Assets History

Loading

Deciphera Pharmaceuticals vs. peers: Current Assets Comparison

Loading

Deciphera Pharmaceuticals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Deciphera Pharmaceuticals (DCPH) FAQ

Deciphera Pharmaceuticals (DCPH) currently reports a current assets of $350M as of March 2024. That compares with $480M in the prior-year period — down 26.5% year over year. Use the charts on this page to explore Deciphera Pharmaceuticals's current assets history and peer comparisons.

Deciphera Pharmaceuticals's current assets decreased from $480M to $350M — a 26.5% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Deciphera Pharmaceuticals reported $350M in current assets as of March 2024. That compares with $480M in the prior-year period — down 26.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $350M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Deciphera Pharmaceuticals, and consider following DCPH for alerts when major investors trade the stock.

Deciphera Pharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $350M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DCPH with unrelated industries.